Global Pharmacovigilance Market Size By Type (Spontaneous Reporting, Intensified ADR Reporting), By Application (Pre-chemicals, Phase I), By End-Use (Hospitals, Pharma & Biotech Companies), By Geographic Scope And Forecast

Pharmacovigilance Market Size And Forecast

Pharmacovigilance Market size was valued at USD 7.80 Billion in 2022 and is projected to reach USD 17.5 Billion by 2030, growing at a CAGR of 10.6% from 2023 to 2030.

With the rising rate of antagonistic medication responses and expanding interest for more secure medications, the requirement for pharmacovigilance has expanded. The Global Pharmacovigilance Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Pharmacovigilance Market Definition

The science and activities of pharmacovigilance are concerned with the detection, evaluation, comprehension, and prevention of adverse effects or other drug-related issues brought on using pharmaceutical products. It is essential to public health and safety because it ensures that drugs are used safely and effectively. Pharmacovigilance’s primary objective is to provide healthcare professionals and the public with timely, accurate information to ensure patient safety. It involves keeping an eye on how safe drugs are from the time regulatory authorities give them their go-ahead to be used to the point where patients use them a lot. Pharmacovigilance means to identify, survey, comprehend, and forestall any unfriendly impacts or other medication-related issues related to the utilization of meds.

The process of gathering, analyzing, and reporting adverse drug-related events is known as pharmacovigilance. Any adverse effect of a drug, including side effects, drug interactions, and medication errors, is considered an adverse event. In addition, pharmacovigilance entails monitoring drug safety in particular populations, such as children and pregnant women, who may be more susceptible to adverse drug effects. Pharmacovigilance is a dynamic field that is always changing due to technological advancements and shifts in drug use patterns. Professionals in pharmacovigilance are now able to identify drug-related potential safety issues quickly and effectively thanks to advancements in artificial intelligence and data mining.

Global Pharmacovigilance Market Overview

With the rising rate of antagonistic medication responses and expanding interest for more secure medications, the requirement for pharmacovigilance has expanded. The development of the pharmacovigilance market is greatly aided by this. additionally, The developing number of clinical preliminaries being led overall has likewise prompted an expansion in the interest for pharmacovigilance administrations. Since new drugs are tested in clinical trials, it is critical to monitor their safety to ensure that patients are not harmed.

The market’s expansion is significantly impeded by the high cost of pharmacovigilance services. The cost of pharmacovigilance services may be prohibitive for particularly small and medium-sized pharmaceutical companies, limiting market expansion. Also, a major obstacle to the market’s expansion is a lack of skilled pharmacovigilance professionals. Pharmacovigilance professionals are in high demand, but there is a limited supply, which may result in higher prices and longer turnaround times for services.

The pharmacovigilance market has significant growth potential in emerging markets like Asia-Pacific, Latin America, and the Middle East. The developing drug industry in these districts and the rising interest in medical care administrations are supposed to drive the development of the pharmacovigilance market in these locales.

Global Pharmacovigilance Market Segmentation Analysis

The Global Pharmacovigilance Market is Segmented on the Basis of Type, Application, End-Use, And Geography.

Pharmacovigilance Market, By Type

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Based on Type, the market is segmented into Cohort Event Monitoring, Spontaneous Reporting, Targeted Spontaneous Reporting, Intensified ADR Reporting, and EHR Mining. Due to its efficient and reasonably priced method of gathering information on suspected ADRs, the spontaneous monitoring segment accounted for a significant share. Additionally, the primary objective is to locate novel, uncommon, and adverse ADRs that were overlooked in pre-marketing clinical trials. Spontaneous reporting occurs throughout the life of a drug, beginning on the day it is introduced to the market. Additionally, this method is advantageous because it provides data from actual clinical practice as opposed to clinical trials, in which vulnerable individuals are excluded and treatment duration is limited.

Pharmacovigilance Market, By Application

• Pre-chemicals
• Phase I
• Phase II
• Phase III
• Phase IV

Based on application, the market is segmented into Pre-chemicals, Phase I, Phase II, Phase III, and Phase IV. These technologies provide an additional degree of protection for medications in clinical trials. Phase IV is an important element of clinical trials because it allows for the detection of unexpected adverse medication effects. Because of the comprehensive drug testing on a large patient base at this stage, it is expected that the data collected and analysed will be critical following the medicine’s commercialization..

Pharmacovigilance Market, By End-Use

• Hospitals
• Pharma & Biotech Companies
• Others

Based on End-Use, the market is segmented into Hospitals, Pharma & Biotech Companies, and Others. In the global market, Pharma & Biotech Companies held the leading position. As a result of pharmaceutical companies’ extensive research and development efforts.

Pharmacovigilance Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, The Global Pharmacovigilance Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Due to the presence of major pharmaceutical and medical device companies that contributed to the region’s overall revenue, North America dominated the market. Rising drug addiction and adverse drug reactions are major causes of illness and mortality. This serves as a strong development delivering component for the North American market. Regional market expansion is also expected to be supported by increased investments in novel drug development by leading players. As a result of the huge drug production, the number of clinical studies and the need for post-marketing surveillance has expanded, contributing to the total expansion.

Key Players

The “Global Pharmacovigilance Market” study report will provide valuable insight with an emphasis on the global market. The major players in the Global Pharmacovigilance Market market are BioClinica Inc., Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, IQVIA, TAKE Solutions Ltd., PAREXEL International and Wipro Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In June 2021- Fiore Healthcare Advisors, LLC has been acquired by SSI Strategy, LLC. By bringing on board a team of seasoned Safety Physicians and Clinical Research support, SSI’s already strong Clinical Research and Drug Safety services will be expanded.
• In April 2021- ResoluteAl, a science research platform, has announced the availability of a series of tools to simplify post-market surveillance and PV analysis.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Pharmacovigilance Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in the Global Pharmacovigilance Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.